Launched on February 5, 2001, the iShares Biotechnology ETF (IBB) is a passively managed exchange traded fund designed to ...

Boost ROI through AI-led discovery, scalable bioprocessing, marine waste valorization, and traceable sourcing that reduces risk and accelerates commercialization.Dublin, Oct. (GLOBE NEWSWIRE) -- ...

Biotechnology is a broad discipline in which biological processes, organisms, cells or cellular components are exploited to develop new technologies. New tools and products developed by ...

The National Security Commission on Emerging Biotechnology visited UW–Madison to discuss Wisconsin’s biohealth strengths, ...

Vir Biotechnology, Inc. (Nasdaq: VIR), today announced the appointment of Suzanne Topalian, M.D., to its Board of Directors, ...

Vir Biotechnology is approaching multiple clinical readouts from drugs with positive data previously. Click here to read an ...

In this column, the author discusses how food biotechnology is evolving from scientific innovation into a scalable ...

Subcutaneous administration is designed to widen the therapeutic window and extend FL115’s potential across a broad range of ...

In recent years, China has accelerated its expansion in Latin America’s biotechnology sector, investing in production ...

The Treasury Department’s proposed restrictions on U.S. investment in Chinese biopharma collide with Beijing’s new export ...

Nautilus Biotechnology, Inc. reported its financial results for the third quarter ended September 30, 2026. Revenue was $0.2 million for the third quarter of 2026, primarily driven by grant revenue ...

Stem cell biotechnology is a field of biotechnology that develops tools and therapeutics through modification and engineering of stem cells. Stem cell biotechnology is important in regenerative ...